Acrospire Investment Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,401
Closed -$64K 646
2017
Q2
$64K Buy
1,401
+201
+17% +$8.87K 0.06% 615
2017
Q1
$51K Sell
1,200
-3,900
-76% -$159K 0.04% 930
2016
Q4
$205K Sell
5,100
-200
-4% -$7.72K 0.08% 342
2016
Q3
$206K Sell
5,300
-900
-15% -$34K 0.14% 147
2016
Q2
$215K Sell
6,200
-2,300
-27% -$79.6K 0.16% 49
2016
Q1
$293K Buy
+8,500
New +$296K 0.2% 43

Other funds holding HOLX

Acrospire Investment Management's HOLX Position: Q3 2017 in Review

Acrospire Investment Management sold out of Hologic (HOLX) in Q3 2017, closing a stake of 1,401 shares — an estimated $64K sold.

Acrospire Investment Management first reported a position in HOLX in Q1 2016 and held it in 6 quarters. The position peaked at $293K in Q1 2016. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

  • Acrospire Investment Management reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,401 Hologic shares in Q3 2017, an estimated $64K.
  • Acrospire Investment Management first reported a position in Hologic in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Hologic position peaked at $293K in Q1 2016.
  • 457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.